课题基金 / 基金详情

Role of USP19 in unconventional secretion of misfolded proteins

Role of USP19 in unconventional secretion of misfolded proteins
USP19 在错误折叠蛋白非常规分泌中的作用
批准号:
9549991
负责人:
Yihong Ye
金额:
$46.89万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Yihong Ye的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To safeguard the proteomic integrity, cells rely on the proteasome to degrade aberrant polypeptides and the lysosomes to degrade large insoluble protein aggregates. However, it is unclear how cells remove defective proteins that have escaped degradation owing to proteasome insufficiency or dysfunction in the lysosome. By study the function of USP19, an endoplamsic reticulum-associated deubiquitinase, we have uncovered a pathway termed misfolding-associated protein secretion. This process uses USP19 to preferentially export aberrant cytosolic proteins. Intriguingly, the catalytic domain of USP19 possesses an unprecedented chaperone activity, allowing recruitment of misfolded proteins to the ER surface for deubiquitylation. Deubiquitylated cargos are encapsulated into ER-associated late endosomes and secreted to the cell exterior. USP19-deficient cells cannot efficiently secrete unwanted proteins and grow more slowly than wild-type cells on exposure to a proteasome inhibitor. Together, our findings delineate a protein quality control (PQC) pathway, which, unlike degradation-based PQC mechanisms, promotes protein homeostasis by exporting misfolded proteins through an unconventional protein secretion process.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanism of protein quality control at the endoplasmic reticulum
Regulation of TNFa signaling by the dual ubiquitin modifying enzyme A20
Mechanism of protein quality control at the endoplasmic reticulum
Mechanism of protein retro-translocation from the endoplasmic reticulum
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: